Breaking News Instant updates and real-time market news.

OGI

Organigram

$2.46 /

+0.06 (+2.50%)

10:10
09/23/21
09/23
10:10
09/23/21
10:10

Size call buyer opens position in Organigram Holdings

Size call buyer opens position in Organigram Holdings. Shares of the Canadian cannabis name up 7c, or 2.7% this morning to $2.48 with calls leading puts 11k to 12 after a large block on NYSE-Arca, where a customer paid 25c for 10k Nov 2.5 calls to open a new position. Delta impact is near 500k shares, or 10% the adv in the stock which has traded between $1 and $6 over the past year.

OGI Organigram
$2.46 /

+0.06 (+2.50%)

07/15/21 Stifel
Organigram price target lowered to C$3.75 from C$4 at Stifel
07/14/21 CIBC
Organigram price target raised to C$4 from C$3.75 at CIBC
06/11/21 CIBC
Organigram price target raised to C$3.75 from C$3.25 at CIBC
05/11/21 CIBC
Organigram upgraded to Neutral from Underperformer at CIBC

TODAY'S FREE FLY STORIES

Recommendations
NCR Corp. price target lowered to $54 from $59 at RBC Capital » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
NCR

NCR Corp.

$41.51 /

-0.905 (-2.13%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

08/04/21 Morgan Stanley
Morgan Stanley trims NCR Corp. price target to $61, says 'buy the dip'
08/04/21 RBC Capital
NCR Corp. price target raised to $59 from $47 at RBC Capital
06/10/21 Morgan Stanley
Seagate, Dell, NCR, NetApp top picks in IT Hardware at Morgan Stanley
05/10/21 Morgan Stanley
NCR Corp. price target raised to $62 from $53 at Morgan Stanley
NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

Hot Stocks
Else Nutrition announces performance results on Amazon » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
BABYF

Else Nutrition

$1.40 /

+ (+0.00%)

, AMZN

Amazon.com

$3,376.16 /

+57.2 (+1.72%)

ELSE NUTRITION HOLDINGS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BABYF Else Nutrition
$1.40 /

+ (+0.00%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

BABYF Else Nutrition
$1.40 /

+ (+0.00%)

05/03/21 Canaccord
Else Nutrition price target lowered to C$5.75 from C$6.50 at Canaccord
12/07/20 Canaccord
Else Nutrition initiated with a Speculative Buy at Canaccord
AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

10/25/21 Wedbush
E-commerce share gains, advertiser demand to drive Amazon Q3 beat, says Wedbush
10/22/21 Credit Suisse
Amazon price target lowered to $4,200 from $4,700 at Credit Suisse
10/21/21 Baird
Amazon executive commentary on supply chain 'largely positive,' says Baird
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

Earnings
Silgan Holdings reports Q3 adjusted EPS $1.02, consensus $1.04 » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
SLGN

Silgan Holdings

$39.16 /

-0.15 (-0.38%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

10/05/21 Loop Capital
Loop starts Silgan with Buy amid 'meaningful growth' in North America
10/05/21 Loop Capital
Silgan Holdings initiated with a Buy at Loop Capital
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
10/01/21 JPMorgan
Silgan Holdings downgraded to Underweight from Neutral at JPMorgan
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

Recommendations
Google wins 'hide and seek,' says Bernstein » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
GOOGL

Alphabet Class A

$2,784.05 /

+39.3 (+1.43%)

, GOOG

Alphabet

$2,794.00 /

+22.64 (+0.82%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

, SNAP

Snap

$55.40 /

+0.925 (+1.70%)

, FB

Facebook

$315.80 /

-12.86 (-3.91%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

07:11 Today Canaccord
Alphabet price target raised to $3350 from $3100 at Canaccord
06:55 Today Barclays
Alphabet price target raised to $3,300 from $3,200 at Barclays
06:38 Today Mizuho
Alphabet price target raised to $3,350 from $3,100 at Mizuho
06:16 Today JMP Securities
Alphabet Class A price target raised to $3,300 from $3,100 at JMP Securities
GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

06:55 Today Barclays
Alphabet price target raised to $3,300 from $3,200 at Barclays
06:38 Today Mizuho
Alphabet price target raised to $3,350 from $3,100 at Mizuho
06:09 Today Piper Sandler
Alphabet price target raised to $3,150 from $3,034 at Piper Sandler
10/26/21 Morgan Stanley
Facebook price target lowered to $365 from $400 at Morgan Stanley
AAPL Apple
$149.26 /

+0.6 (+0.40%)

07:15 Today Canaccord
Twitter price target lowered to $72 from $78 at Canaccord
07:14 Today Bernstein
Twitter reports 'clean quarter,' says Bernstein
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
SNAP Snap
$55.40 /

+0.925 (+1.70%)

10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Wells Fargo
Facebook price target lowered to $425 from $450 at Wells Fargo
10/24/21 BofA
Snap price target lowered to $67 from $80 at BofA
10/22/21 RBC Capital
Snap price target lowered to $70 from $88 at RBC Capital
FB Facebook
$315.80 /

-12.86 (-3.91%)

10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Monness Crespi
Facebook price target lowered to $460 from $500 at Monness Crespi
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Earnings
Acceleron expects Q3 royalty revenue of approximately $32M from Reblozy » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
XLRN

Acceleron

$173.85 /

+0.23 (+0.13%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

Acceleron Pharma (XLRN) …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

10/06/21 Jefferies
Acceleron initiated with a Hold at Jefferies
10/04/21 Raymond James
Acceleron downgraded to Market Perform from Strong Buy at Raymond James
10/01/21 Barclays
Acceleron downgraded to Equal Weight from Overweight at Barclays
09/30/21 Cowen
Acceleron downgraded to Market Perform from Outperform at Cowen
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

Earnings
Silicon Labs sees Q4 non-GAAP EPS50c-60c , consensus 19c » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
SLAB

Silicon Labs

$154.95 /

+0.69 (+0.45%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

10/19/21 Stifel
Ambarella price target raised to $185 from $145 at Stifel
05/19/21
Fly Intel: Top five analyst downgrades
05/19/21 Citi
Silicon Labs downgraded to Neutral from Buy at Citi
04/29/21 JPMorgan
Silicon Labs downgraded to Neutral on valuation at JPMorgan
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

Earnings
GlaxoSmithKline raises 2021 EPS guidance, confirms 2022 outlook » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
GSK

GlaxoSmithKline

$40.18 /

+0.375 (+0.94%)

Glaxo said: "GSK now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

Earnings
Sharps Compliance reports Q1 EPS (4c), consensus (3c) » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
SMED

Sharps Compliance

$8.02 /

-0.18 (-2.20%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

08/20/21 Barrington
Sharps Compliance price target lowered to $13 from $18 at Barrington
05/06/21 Barrington
Sharps Compliance price target raised to $18 from $15 at Barrington
04/29/21 H.C. Wainwright
Sharps Compliance price target raised to $25 from $18 at H.C. Wainwright
03/23/21 Roth Capital
Sharps Compliance target raised to $16 at Roth Capital on Mailback strength
SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

  • 26
    Aug
Hot Stocks
Portillo's annnounces closing of IPO, full exercise of underwriters' option » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
PTLO

Portillo’s

$41.99 /

-0.02 (-0.05%)

Portillo's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 21
    Oct
PTLO Portillo’s
$41.99 /

-0.02 (-0.05%)

Hot Stocks
Nurix Therapeutics announces initial data from Phase 1a trial of NX-2127 » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
NRIX

Nurix Therapeutics

$28.77 /

+0.58 (+2.06%)

Nurix Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

10/14/21 SVB Leerink
Nurix Therapeutics initiated with an Outperform at SVB Leerink
06/03/21 Baird
Nurix Therapeutics transferred with Outperform at Baird
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 RBC Capital
Nurix Therapeutics initiated with an Outperform at RBC Capital
NRIX Nurix Therapeutics
$28.77 /

+0.58 (+2.06%)

  • 05
    Mar
Earnings
Teva backs FY21 EPS view $2.50-$2.70, consensus $2.58 » 07:15
10/27/21
10/27
07:15
10/27/21
07:15
TEVA

Teva

$9.40 /

-0.735 (-7.25%)

Backs FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

Recommendations
Twitter price target lowered to $72 from $78 at Canaccord » 07:15
10/27/21
10/27
07:15
10/27/21
07:15
TWTR

Twitter

$61.40 /

-0.71 (-1.14%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

Canaccord analyst Maria…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

07:14 Today Bernstein
Twitter reports 'clean quarter,' says Bernstein
07:02 Today Barclays
Twitter price target raised to $64 from $60 at Barclays
05:01 Today Piper Sandler
Twitter price target lowered to $70 from $76 at Piper Sandler
10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
AAPL Apple
$149.26 /

+0.6 (+0.40%)

07:14 Today Bernstein
Twitter reports 'clean quarter,' says Bernstein
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Earnings
Silicon Labs reports Q3 non-GAAP EPS 34c, consensus 15c » 07:15
10/27/21
10/27
07:15
10/27/21
07:15
SLAB

Silicon Labs

$154.95 /

+0.69 (+0.45%)

Reports Q3 cont-op…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

10/19/21 Stifel
Ambarella price target raised to $185 from $145 at Stifel
05/19/21
Fly Intel: Top five analyst downgrades
05/19/21 Citi
Silicon Labs downgraded to Neutral from Buy at Citi
04/29/21 JPMorgan
Silicon Labs downgraded to Neutral on valuation at JPMorgan
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

General news
FX Update: The dollar has been trading mixed » 07:15
10/27/21
10/27
07:15
10/27/21
07:15
$ECON

Economic Data

/

+

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
C.H. Robinson price target raised to $105 from $100 at BMO Capital » 07:14
10/27/21
10/27
07:14
10/27/21
07:14
CHRW

C.H. Robinson

$98.52 /

+0.47 (+0.48%)

BMO Capital analyst Fadi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$98.52 /

+0.47 (+0.48%)

CHRW C.H. Robinson
$98.52 /

+0.47 (+0.48%)

10/11/21 Vertical Research
C.H. Robinson upgraded to Buy from Hold at Vertical Research
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Evercore ISI
Evercore ISI starts C.H. Robinson at In Line with $95 price target
09/13/21 Evercore ISI
C.H. Robinson initiated with an In Line at Evercore ISI
CHRW C.H. Robinson
$98.52 /

+0.47 (+0.48%)

CHRW C.H. Robinson
$98.52 /

+0.47 (+0.48%)

Recommendations
Twitter reports 'clean quarter,' says Bernstein » 07:14
10/27/21
10/27
07:14
10/27/21
07:14
TWTR

Twitter

$61.40 /

-0.71 (-1.14%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

Commenting on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

07:02 Today Barclays
Twitter price target raised to $64 from $60 at Barclays
05:01 Today Piper Sandler
Twitter price target lowered to $70 from $76 at Piper Sandler
10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
AAPL Apple
$149.26 /

+0.6 (+0.40%)

10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Craig-Hallum
Magnite price target lowered to $45 from $52 at Craig-Hallum
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Earnings
Stifel Financial reports Q3 adjusted EPS $1.65, consensus $1.48 » 07:13
10/27/21
10/27
07:13
10/27/21
07:13
SF

Stifel Financial

$77.33 /

-0.37 (-0.48%)

Reports Q3 revenue $1.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SF Stifel Financial
$77.33 /

-0.37 (-0.48%)

SF Stifel Financial
$77.33 /

-0.37 (-0.48%)

06/23/21 Wolfe Research
Stifel Financial upgraded to Outperform from Underperform at Wolfe Research
04/09/21 JMP Securities
Stifel Financial price target raised to $77 from $60 at JMP Securities
01/29/21 JMP Securities
Stifel Financial price target raised to $60 from $56 at JMP Securities
01/15/21 Wells Fargo
Stifel Financial upgraded to Equal Weight from Underweight at Wells Fargo
SF Stifel Financial
$77.33 /

-0.37 (-0.48%)

SF Stifel Financial
$77.33 /

-0.37 (-0.48%)

Earnings
GlaxoSmithKline reports Q3 adjusted EPS 36.6p vs. 35.6p last year » 07:13
10/27/21
10/27
07:13
10/27/21
07:13
GSK

GlaxoSmithKline

$40.18 /

+0.375 (+0.94%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

Earnings
Virtus Investment reports Q3 adjusted EPS $9.71, consensus $9.60 » 07:13
10/27/21
10/27
07:13
10/27/21
07:13
VRTS

Virtus Investment

$330.40 /

-1.32 (-0.40%)

Reports Q3 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTS Virtus Investment
$330.40 /

-1.32 (-0.40%)

VRTS Virtus Investment
$330.40 /

-1.32 (-0.40%)

08/05/21 Morgan Stanley
Morgan Stanley upgrades Virtus Investment to Overweight on better EPS growth
08/05/21 Morgan Stanley
Virtus Investment upgraded to Overweight from Equal Weight at Morgan Stanley
02/03/21 Barclays
Virtus Investment price target raised to $315 from $280 at Barclays
01/25/21 Barclays
Virtus Investment price target raised to $280 from $270 at Barclays
VRTS Virtus Investment
$330.40 /

-1.32 (-0.40%)

Hot Stocks
Recro Pharma enters into master commercial supply agreement with Otsuka » 07:13
10/27/21
10/27
07:13
10/27/21
07:13
REPH

Recro Pharma

$1.76 /

+0.02 (+1.15%)

, OTSKY

Otsuka

$20.34 /

+0.03 (+0.15%)

Recro Pharma (REPH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REPH Recro Pharma
$1.76 /

+0.02 (+1.15%)

OTSKY Otsuka
$20.34 /

+0.03 (+0.15%)

REPH Recro Pharma
$1.76 /

+0.02 (+1.15%)

10/12/21 William Blair
Recro Pharma initiated with an Outperform at William Blair
01/04/21 Craig-Hallum
Recro Pharma initiated with a Buy at Craig-Hallum
OTSKY Otsuka
$20.34 /

+0.03 (+0.15%)

07/14/21 Goldman Sachs
Otsuka downgraded to Sell from Neutral at Goldman Sachs
06/17/21 Daiwa
Otsuka upgraded to Outperform from Neutral at Daiwa
03/15/21 Daiwa
Otsuka downgraded to Neutral from Outperform at Daiwa
  • 12
    May
Earnings
Teva reports Q3 EPS 59c, consensus 65c » 07:12
10/27/21
10/27
07:12
10/27/21
07:12
TEVA

Teva

$9.40 /

-0.735 (-7.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

TEVA Teva
$9.40 /

-0.735 (-7.25%)

Recommendations
InMode price target raised to $100 from $80 at Canaccord » 07:12
10/27/21
10/27
07:12
10/27/21
07:12
INMD

InMode

$87.75 /

+0.31 (+0.35%)

Canaccord analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$87.75 /

+0.31 (+0.35%)

INMD InMode
$87.75 /

+0.31 (+0.35%)

06:32 Today Baird
InMode price target raised to $96 from $80 at Baird
10/13/21 Canaccord
InMode price target raised to $80 from $60 at Canaccord
10/13/21 Baird
InMode price target raised to $80 from $62 at Baird
10/13/21 Barclays
InMode price target raised to $85 from $60 at Barclays
INMD InMode
$87.75 /

+0.31 (+0.35%)

INMD InMode
$87.75 /

+0.31 (+0.35%)

INMD InMode
$87.75 /

+0.31 (+0.35%)

Earnings
New York Community Bancorp reports Q3 adjusted EPS 31c, consensus 32c » 07:12
10/27/21
10/27
07:12
10/27/21
07:12
NYCB

New York Community Bancorp

$13.94 /

-0.02 (-0.14%)

Reports Q3 revenue $333M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

10/01/21 B. Riley
New York Community shares 'should re-rate higher,' says B. Riley
05/04/21 Raymond James
Flagstar Bancorp downgraded to Market Perform from Strong Buy at Raymond James
05/03/21 Deutsche Bank
New York Community Bancorp price target raised to $15 from $11.50 at Deutsche Bank
04/27/21 Wedbush
Flagstar Bancorp downgraded to Neutral from Outperform at Wedbush
NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

NYCB New York Community Bancorp
$13.94 /

-0.02 (-0.14%)

Hot Stocks
GasLog Partners announces LNG market update, outlook » 07:12
10/27/21
10/27
07:12
10/27/21
07:12
GLOP

GasLog Partners

$5.30 /

-0.205 (-3.73%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOP GasLog Partners
$5.30 /

-0.205 (-3.73%)

GLOP GasLog Partners
$5.30 /

-0.205 (-3.73%)

10/22/21 Jefferies
Jefferies upgrades GasLog Partners to Buy on stronger rates into 2022
10/22/21 Jefferies
GasLog Partners upgraded to Buy from Hold at Jefferies
07/27/21 Jefferies
Jefferies cuts GasLog Partners to Hold, citing valuation
07/27/21 Jefferies
GasLog Partners downgraded to Hold from Buy at Jefferies
GLOP GasLog Partners
$5.30 /

-0.205 (-3.73%)

Recommendations
Alphabet price target raised to $3350 from $3100 at Canaccord » 07:11
10/27/21
10/27
07:11
10/27/21
07:11
GOOGL

Alphabet Class A

$2,784.05 /

+39.3 (+1.43%)

Canaccord analyst Maria…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

06:55 Today Barclays
Alphabet price target raised to $3,300 from $3,200 at Barclays
06:38 Today Mizuho
Alphabet price target raised to $3,350 from $3,100 at Mizuho
06:16 Today JMP Securities
Alphabet Class A price target raised to $3,300 from $3,100 at JMP Securities
06:09 Today Piper Sandler
Alphabet price target raised to $3,150 from $3,034 at Piper Sandler
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.